(Bloomberg) — British Columbia Investment Management Corp. and Preservation Capital Partners are considering a sale of BMS Group that could value the insurance broker at more than £600 million ($720 ...

Bristol-Myers Squibb (BMS) said today it will acquire Padlock Therapeutics for up to $600 million in a deal that expands the buyer’s pipeline in autoimmune diseases, including rheumatoid arthritis.

Bristol-Myers Squibb is to buy US biotech Padlock Therapeutics, which aims to create treatments for serious autoimmune diseases, in a deal worth up to $600 million. BMS said it will acquire all ...

MOTORCYCLES/ATVS/UTILITY - Due to limited resale market, we are unable to determine used values. Make sure you're protected! Insure your Utility Vehicles for as low ...